高级搜索
赵春燕, 陈海珍, 蔡波, 陈建国, 蔡娟. 南通户籍宫颈癌患者生存现状分析[J]. 肿瘤防治研究, 2024, 51(1): 61-66. DOI: 10.3971/j.issn.1000-8578.2024.23.0489
引用本文: 赵春燕, 陈海珍, 蔡波, 陈建国, 蔡娟. 南通户籍宫颈癌患者生存现状分析[J]. 肿瘤防治研究, 2024, 51(1): 61-66. DOI: 10.3971/j.issn.1000-8578.2024.23.0489
ZHAO Chunyan, CHEN Haizhen, CAI Bo, CHEN Jianguo, CAI Juan. Survival Status of Patients with Cervical Cancer Registered in Nantong[J]. Cancer Research on Prevention and Treatment, 2024, 51(1): 61-66. DOI: 10.3971/j.issn.1000-8578.2024.23.0489
Citation: ZHAO Chunyan, CHEN Haizhen, CAI Bo, CHEN Jianguo, CAI Juan. Survival Status of Patients with Cervical Cancer Registered in Nantong[J]. Cancer Research on Prevention and Treatment, 2024, 51(1): 61-66. DOI: 10.3971/j.issn.1000-8578.2024.23.0489

南通户籍宫颈癌患者生存现状分析

Survival Status of Patients with Cervical Cancer Registered in Nantong

  • 摘要:
    目的 对南通市肿瘤医院2002—2017年南通户籍宫颈癌住院患者作生存现状分析。
    方法 采用主被动随访相结合的方法,对南通市肿瘤医院2002—2017年南通户籍宫颈癌住院病例开展生存结局的随访,随访截至2020年12月31日。χ2检验对失访率进行统计分析;寿命表法计算各年观察生存率,R语言法绘制生存曲线,Log rank(Mantel-Cox)进行不同年龄组、不同来源地区病例生存率的差异比较。
    结果 宫颈癌登记病例5 645例,获得生存结局的5 512例,随访成功率97.64%。患者平均发病年龄为(56.67±12.78)岁中位生存时间为6.54年,1、3、5及10年观察生存率分别为91.50%、76.95%、60.99%及28.51%。15~岁组与60~岁组(χ2=7.469, P=0.006)、15~岁组与80~岁组(χ2=36.317, P < 0.001)生存率差异均有统计学意义。海门籍与启东籍(χ2=2.779, P=0.095)、启东籍与通州籍(χ2=0.515, P=0.473)生存率差异无统计学意义。其余各地区间生存率两两比较,差异均有统计学意义(均P < 0.05)。
    结论 本组以医院为基础的宫颈癌登记病例各年龄组和不同来源地区的生存率比较差异均有统计学意义,且生存率随年龄增长而显著下降。较高的病例随访率完整体现了南通市肿瘤医院南通户籍宫颈癌患者治疗的综合效果。

     

    Abstract:
    Objective To analyze the survival status of inpatients with cervical cancer registered in Nantong admitted in Nantong Cancer Hospital from 2002 to 2017.
    Methods Inpatients with cervical cancer in Nantong Cancer Hospital were followed up from 2017 until December 31, 2020 using active and passive methods to determine their survival outcome. The rate of follow-up loss was statistically analyzed by Chi-square test, the observed survival rate for each year was calculated using the life table, the survival curve was drawn with R language, and the survival rates of patients in different age groups and from different regions were compared with log-rank test (Mantel-Cox).
    Results A total of 5645 cervical cancer cases were registered. Among them, the survival outcome was recorded for 5512 cases. The success rate of follow-up was 97.64%, and the loss of follow-up rate was 2.36%. The average age of onset was 56.67±12.78 years. The median survival time was 6.54 years, and the 1-, 3-, 5-, and 10-year observed survival rates were 91.50%, 76.95%, 60.99%, and 28.51%, respectively. Among the age groups, significant differences in survival rate were observed between the 15- and 60-year-old groups (χ2=7.469, P=0.006) and between the 15- and 80-year-old groups (χ2=36.317, P < 0.001). No significant difference in survival rate was found between patients from Haimen and Qidong (χ2=2.779, P=0.095) and between patients from Qidong and Tongzhou (χ2=0.515, P=0.473). Significant difference in survival rate was observed among other regions (P < 0.05).
    Conclusion In this study group, the survival rates of hospital-based patients with cervical cancer significantly differ among the age groups and regions of origin and significantly decreased with age. The high follow-up rate fully reflects the comprehensive effect of the treatment in Nantong Cancer Hospital for registered patients with cervical cancer in Nantong.

     

/

返回文章
返回